Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Rather than dismissing his interest, I suggested a compromise: He could try the ACV approach, but wed monitor his blood sugar closely, and if we didnt see meaningful improvement within a month, hed start the medication
At the end of the day, more research is needed in this area
Injection site reactions, including erythema, pruritus, and nodule formation (particularly with extended-release formulations), occur in approximately 10-20% of patients
Billing is monthly and injection-only, with nothing charged until a licensed provider approves the prescription
Nausea is one of the most commonly reported side effects of weight loss injections, particularly those containing GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda)
Clinical Data Clinical Trial Results 28.7% Average Weight Loss 68 weeks 58.6% Achieved 25%+ Loss of participants 445 Trial Participants Phase 3 Data from the Phase 3 TRIUMPH-4 trial of retatrutide, reported by Eli Lilly (topline, 2025)
US$ 28.78
US$ 27.95
US$ 27.59
US$ 29.72
US$ 23.77
US$ 25.34
US$ 24.74
US$ 20.60
